Education
About Us
Working with TipRanks
Follow Us
Hemostemix Inc (TSE:HEM)
:HEM
Total Valuation
Hemostemix has a market cap or net worth of C$13.81M. The enterprise value is C$12.99M.
Market CapC$13.81M
Enterprise ValueC$12.99M
Share Statistics
Hemostemix has 148,456,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding148,456,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hemostemix’s return on equity (ROE) is 0.34 and return on invested capital (ROIC) is 91.05%.
Return on Equity (ROE)0.34
Return on Assets (ROA)-7.97
Return on Invested Capital (ROIC)91.05%
Return on Capital Employed (ROCE)0.91
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Hemostemix is -2.31. Hemostemix’s PEG ratio is 0.04.
PE Ratio-2.31
PS Ratio―
PB Ratio-0.78
Price to Fair Value-0.78
Price to FCF-4.07
Price to Operating Cash Flow-4.07
PEG Ratio0.04
Income Statement
In the last 12 months, Hemostemix had revenue of 0.00 and earned -2.50M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit-223.00
Operating Income-2.33M
Pretax Income-2.50M
Net Income-2.50M
EBITDA-1.95M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -332.57K and capital expenditures 0.00, giving a free cash flow of -332.57K billion.
Operating Cash Flow-332.57K
Free Cash Flow-332.57K
Free Cash Flow per Share>-0.01
Dividends & Yields
Hemostemix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.28
52-Week Price Change80.00%
50-Day Moving Average0.14
200-Day Moving Average0.11
Relative Strength Index (RSI)32.87
Average Volume (3m)150.40K
Important Dates
Hemostemix upcoming earnings date is May 6, 2025, TBA Not Confirmed.
Last Earnings DateNov 29, 2024
Next Earnings DateMay 6, 2025
Ex-Dividend Date―
Financial Position
Hemostemix as a current ratio of 0.11, with Debt / Equity ratio of -55.07%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap0.75
Net Debt to EBITDA-2.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hemostemix has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hemostemix EV to EBITDA ratio is -5.11, with an EV/FCF ratio of -7.00.
EV to Sales0.00
EV to EBITDA-5.11
EV to Free Cash Flow-7.00
EV to Operating Cash Flow-7.00
Balance Sheet
Hemostemix has C$63.33K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$4.71M billion.
Cash & Marketable SecuritiesC$63.33K
Total DebtC$0.00
Net CashC$4.71M
Net Cash Per ShareC$0.03
Tangible Book Value Per Share-C$0.09
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Hemostemix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast43.45%